Genocea Biosciences Inc expected to post a loss of 18  cents a share - Earnings Preview

Genocea Biosciences

19/07/2021 13:46

* Genocea Biosciences Inc  GNCA.OQ   GNCA.O  is expected to show
a fall in quarterly revenue when it reports results on July 21
(estimated) .
​* Refinitiv's mean analyst estimate for Genocea Biosciences Inc
is for a loss of 18 cents per share. For the same quarter last
year, the company reported a loss of 39 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Genocea
Biosciences Inc is $6​, about 64.8% above​ its last closing
price of $2.12. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.20       -0.20      -0.17     Beat    14.1
 Dec. 31 2020  -0.21       -0.21      -0.23     Missed  -10.6
 Sep. 30 2020  -0.25       -0.24      -0.08     Beat    66.9​
 Jun. 30 2020  -0.41       -0.40      -0.39     Beat    3.7
 Mar.          -0.34​      -0.35      -0.46     Missed  -30.7​
 31​ 2020​                                              
 Dec. 31 2019  -0.37       -0.39      -0.34     Beat    12.8​
 Sep. 30 2019  -0.45       -0.46      -0.28     Beat    38.8
 Jun. 30 2019  -0.62       -0.66      -0.42     Beat    36.1
 This summary was machine generated July 19 at 12:46 GMT.  All
figures in US dollars unless otherwise stated